Portfolio company
Vaccitech Ltd
United Kingdom · £143m raised
Raised
£143m
Latest stage
Series B
Rounds recorded
2
Backed by
3 investors
Sectors
About
This biopharmaceutical company develops immunotherapeutic products and vaccines for patients with chronic infectious diseases, autoimmune conditions and cancer.
SourceFunding history · 2
Similar companies
Barinthus Biotherapeutics
This biopharmaceutical company develops antigen-specific immunotherapies and vaccines to treat patients with chronic infectious diseases, autoimmunity and cancer.
Nykode Therapeutics
This company develops immunotherapy vaccines to treat patients with cancer and autoimmune diseases.
Immunocore
This biotechnology company develops T cell receptor immunotherapies to treat patients with cancer, infectious diseases and autoimmune conditions.
immunique
This company develops immune therapeutics, including cell therapies and peptides, for patients with cancer and autoimmune diseases.
Pharmexa A/S
This company develops active immunotherapy and peptide vaccines for patients with cancer, chronic illnesses, and infectious diseases.
Hookipa Pharma
This biopharmaceutical company develops arenavirus-based immunotherapies to treat infectious diseases and cancers for patients and healthcare providers.
Baseimmune
The company develops AI-designed vaccines and antigens for pharmaceutical partners and biotech researchers to treat infectious diseases and chronic conditions in humans and animals.
IO Biotech
The company develops immune-modulating therapeutic cancer vaccines to treat patients with melanoma and other solid tumours.
